Neogen Corp. (NEOG)
11.64
+0.04
(+0.34%)
USD |
NASDAQ |
Aug 25, 16:00
12.03
+0.39
(+3.35%)
After-Hours: 07:11
Neogen EPS Diluted (Quarterly) : -0.0519 for May 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.0519 |
| February 28, 2026 | -0.0781 |
| November 30, 2025 | -0.0732 |
| August 31, 2025 | 0.1672 |
| May 31, 2025 | -2.821 |
| February 28, 2025 | -0.0505 |
| November 30, 2024 | -2.104 |
| August 31, 2024 | -0.0582 |
| May 31, 2024 | -0.025 |
| February 29, 2024 | -0.0093 |
| November 30, 2023 | -0.0161 |
| August 31, 2023 | 0.0069 |
| May 31, 2023 | 0.0257 |
| February 28, 2023 | 0.0378 |
| November 30, 2022 | -0.1936 |
| August 31, 2022 | 0.0483 |
| May 31, 2022 | 0.1387 |
| February 28, 2022 | 0.0503 |
| November 30, 2021 | 0.1002 |
| August 31, 2021 | 0.158 |
| May 31, 2021 | 0.1459 |
| February 28, 2021 | 0.1246 |
| November 30, 2020 | 0.1487 |
| August 31, 2020 | 0.1488 |
| May 31, 2020 | 0.1539 |
| Date | Value |
|---|---|
| February 29, 2020 | 0.115 |
| November 30, 2019 | 0.1539 |
| August 31, 2019 | 0.1391 |
| May 31, 2019 | 0.1506 |
| February 28, 2019 | 0.1246 |
| November 30, 2018 | 0.1526 |
| August 31, 2018 | 0.145 |
| May 31, 2018 | 0.1673 |
| February 28, 2018 | 0.1588 |
| November 30, 2017 | 0.1234 |
| August 31, 2017 | 0.1162 |
| May 31, 2017 | 0.12 |
| February 28, 2017 | 0.1013 |
| November 30, 2016 | 0.1088 |
| August 31, 2016 | 0.0975 |
| May 31, 2016 | 0.0975 |
| February 29, 2016 | 0.0825 |
| November 30, 2015 | 0.09 |
| August 31, 2015 | 0.0938 |
| May 31, 2015 | 0.0938 |
| February 28, 2015 | 0.075 |
| November 30, 2014 | 0.0788 |
| August 31, 2014 | 0.09 |
| May 31, 2014 | 0.075 |
| February 28, 2014 | 0.0675 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 1.103 |
| Integer Holdings Corp. | 0.6913 |
| Zimmer Biomet Holdings, Inc. | 1.028 |
| iRhythm Holdings, Inc. | -0.0116 |
| Abbott Laboratories | 0.5324 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.30M |
| Revenue (Quarterly) | 225.30M |
| Total Expenses (Quarterly) | 236.60M |
| Enterprise Value | 3.161B |
| Gross Profit Margin (Quarterly) | 37.59% |
| Profit Margin (Quarterly) | -5.02% |
| Earnings Yield | -0.31% |
| Normalized Earnings Yield | -0.1229 |